Literature DB >> 8899149

In vitro comparison of the effects of contrast media on coagulation and platelet activation.

C Corot1, N Chronos, V Sabattier.   

Abstract

The aim of this study was to compare the in vitro effects of different classes of contrast media on both the blood coagulation system and on platelet function. Global tests (APTT, TT) and FpA and F1 + 2 generation measurements showed that ioxaglate (ionic dimer) presents the highest anticoagulant potential. The anticoagulant effects of nonionic agents were less marked, iodixanol (nonionic dimer) being significantly less anticoagulant than iohexol (nonionic monomer). Major platelet activation was observed with release of PF4, serotonin and PDGF-AB when iohexol was incubated for 1 min in whole blood. Iodixanol showed no effect over the same period, while moderate platelet activation was observed after 30 min. Under the same experimental conditions, ioxaglate had no effect on platelets even after incubation for 30 min, whereas activation was observed with 9 g/l saline control at this time. Prevention of thrombin formation and platelet activation is only achieved with ioxaglate, the ionic dimer. These findings may be clinically important in the thrombotic environment of radiological procedures and may explain the increased thrombotic risks observed with nonionic agents in interventional procedures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899149     DOI: 10.1097/00001721-199609000-00005

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  8 in total

Review 1.  Effects of iodinated contrast media on blood and endothelium.

Authors:  Peter Aspelin; Fulvio Stacul; Henrik S Thomsen; Sameh K Morcos; Aart J van der Molen
Journal:  Eur Radiol       Date:  2006-01-05       Impact factor: 5.315

2.  Similar inhibition of platelet adhesion, P-selectin expression and plasma coagulation by ioversol, iodixanol and ioxaglate.

Authors:  J P Fägerstam; A K Ostberg; A C Eriksson; S-G Fransson; P A Whiss
Journal:  Br J Radiol       Date:  2009-06-22       Impact factor: 3.039

3.  An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents.

Authors:  P M Farrehi; Y Zhu; W P Fay
Journal:  J Thromb Thrombolysis       Date:  2001-12       Impact factor: 2.300

Review 4.  Thrombolytics: drug interactions of clinical significance.

Authors:  S Harder; U Klinkhardt
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

5.  Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial.

Authors:  T A Tomsick; L D Foster; D S Liebeskind; M D Hill; J Carrozella; M Goyal; R von Kummer; A M Demchuk; I Dzialowski; V Puetz; T Jovin; H Morales; Y Y Palesch; J Broderick; P Khatri; S D Yeatts
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

6.  The assessment of thrombotic markers utilizing ionic versus non-ionic contrast during coronary angiography and intervention trial.

Authors:  Binita Shah; Jeffrey S Berger; Nicole Allen; Yu Guo; Steven P Sedlis; Jinfeng Xu; Adriana Perez; Michael Attubato; James Slater; Frederick Feit
Journal:  Catheter Cardiovasc Interv       Date:  2016-01-16       Impact factor: 2.692

7.  Iodixanol Has a Favourable Fibrinolytic Profile Compared to Iohexol in Cardiac Patients Undergoing Elective Angiography: A Double-Blind, Randomized, Parallel Group Study.

Authors:  Andrew T Treweeke; Benjamin H Maskrey; Kirsty Hickson; John H Miller; Stephen J Leslie; Ian L Megson
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

8.  Iodixanol as a Contrast Agent in a Fibrin Hydrogel for Endodontic Applications.

Authors:  Gabriel Hertig; Matthias Zehnder; Anna Woloszyk; Thimios A Mitsiadis; Anja Ivica; Franz E Weber
Journal:  Front Physiol       Date:  2017-03-15       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.